Skip to search formSkip to main contentSkip to account menu

AG 1749

Known as: AG-1749, AG1749 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

lansoprazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
[Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
E-3810 and AG-1749, new proton pump inhibitors, were administrated in single doses or over a long period of time in order to… 
1991
1991
Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
The effects of (+/-)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy-2- pyridyl]methyl]sulfinyl]-1H-benzimidazole (lansoprazole, AG-1749… 
1991
1991
Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
1991
1991
Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
1991
1991
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Antisecretory effects of a substituted benzimidazole, (+/-)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl… 
1991
1991
[Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring].
Proton pump inhibitors, as agents for use against peptic ulcers, potently suppress gastric acid secretion, as is the case with H2… 
Highly Cited
1990
Highly Cited
1990
Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
We have reported previously that 2-[[[3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridyl]methyl] sulfinil]- 1H-benzimidazole (AG-1749… 
Highly Cited
1989
Highly Cited
1989
Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
The antisecretory and antiulcer activities of 2[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazole… 
Highly Cited
1989
Highly Cited
1989
Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
Mechanisms related to the inhibition of (H+ + K+)-adenosine triphosphatase (ATPase) by 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2… 
1989
1989
Human gastric acid secretion following repeated doses of AG‐1749
The effect of increasing doses (15 mg, 30 mg and 60 mg) of the substituted benzimidazole, AG‐1749, on gastric acid secretion and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)